Arlington, VA (November 14, 2024) – Cerbrec, a pioneering provider of AI-driven data solutions platform, today announced a strategic partnership with Seek Labs, a healthcare innovations company developing next-generation point-of-care molecular diagnostic systems and programmable rapid response therapeutic technologies.

This partnership will integrate Cerbrec's flagship product, Graphbook, into Seek Labs' operations to enhance their research and development capabilities. Graphbook is a revolutionary high-performance computing platform that simplifies the creation of data processing automation and artificial intelligence through an intuitive drag-and-drop interface. The platform has demonstrated the ability to enhance productivity by 8-10X for biomedical researchers and engineers.

“We’re thrilled to bring Cerbrec’s AI-driven data solutions platform to accelerate Seek Labs’ transformative research and development,” said Garrett Wang, CEO of Cerbrec. “Our strength in high-performance computing addresses challenges in large-scale data processing and data integration. We’re proud to support Seek Labs’ pioneering work in diagnostic and therapeutic innovations.”

The partnership marks a significant milestone for both companies. Seek Labs will immediately implement Graphbook's features into their research and development workflow, particularly focusing on their therapeutic programmable target ablation platform. This integration will help streamline the organization, interpretation, and analysis of complex data sets.

"We are excited to unlock new efficiencies and insights through our exciting partnership with Cerbrec," said Jared Bauer, CEO of Seek Labs. "Graphbook will empower us to address critical healthcare needs through innovative technologies and products faster and with greater precision."

About Cerbrec:

Cerbrec is a cutting-edge data solutions provider specializing in AI-driven platforms. The company's flagship product, Graphbook, is transforming how biomedical researchers and scientists approach AI integration in their work, particularly in drug discovery and clinical trials. Cerbrec is committed to democratizing AI solutions for the life sciences industry.

Press Contact: pr@cerbrec.com